Table of Contents Table of Contents
Previous Page  572 / 1851 Next Page
Information
Show Menu
Previous Page 572 / 1851 Next Page
Page Background

C-RT + Pembrolizumab – a safety study

Powell ASCO 2017

23 (85%) completed ≥ 200 mg cisplatin/m²

27 (100%) completed 70Gy of radiation

1 … 567 568 569 570 571 572 573 574 575 576 577 578-579 … 1851  FlippingBook